STAGE IV UTERINE CORPUS CANCER AJCC V8
Clinical trials for STAGE IV UTERINE CORPUS CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV UTERINE CORPUS CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IV UTERINE CORPUS CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising combo targets recurrent gynecologic cancers
Disease control Recruiting nowThis early-stage trial is testing the drug talazoparib together with radiation therapy for people whose gynecologic cancer (ovarian, endometrial, cervical, or related cancers) has come back. The main goal is to find the safest dose and see how well the combination works at shrink…
Matched conditions: STAGE IV UTERINE CORPUS CANCER AJCC V8
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 22, 2026 12:05 UTC
-
New drug combo trial hopes to tame tough cancers
Disease control Recruiting nowThis early-phase study tests a new drug called IACS-6274, given alone or with other medicines, in people with advanced solid tumors (like melanoma, ovarian, or head and neck cancers) that haven't responded to standard treatments. The main goal is to find the safest dose and under…
Matched conditions: STAGE IV UTERINE CORPUS CANCER AJCC V8
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 22, 2026 12:04 UTC
-
Chemotherapy mist shows promise in targeting stomach, ovarian, and colon cancers
Disease control Recruiting nowThis early-stage trial is testing the safety of a new method called PIPAC, which turns chemotherapy into a fine mist and sprays it directly into the abdomen during a minimally invasive surgery. The study includes adults with ovarian, uterine, appendix, stomach, or colorectal canc…
Matched conditions: STAGE IV UTERINE CORPUS CANCER AJCC V8
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 17, 2026 12:05 UTC
-
Electric field device joins forces with cancer drugs in early trial
Disease control Recruiting nowThis early-phase study tests a wearable device that creates electric fields (tumor treating fields) combined with either cabozantinib or a chemo-immunotherapy pair (nab-paclitaxel and atezolizumab) in people with advanced solid tumors in the abdomen or chest. The goal is to find …
Matched conditions: STAGE IV UTERINE CORPUS CANCER AJCC V8
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 12, 2026 12:08 UTC